TickerFacts.

Immucell Corp (ICCC): Capital Expenditures

Annual figures by period end, from SEC filings.

$1.25M
Year ended 2025-12-31
$1.68M
Trailing 12 months to 2026-06-30
-32.0%
3-year compound annual growth
-21.0%
5-year compound annual growth
-7.5%
10-year compound annual growth
$17.76M2009-12-31: $459.5K2010-12-31: $116.5K2011-12-31: $243.7K2012-12-31: $275.4K2013-12-31: $597.7K2014-12-31: $1.54M2015-12-31: $2.72M2016-12-31: $3.59M2017-12-31: $17.76M2018-12-31: $2.03M2019-12-31: $1.39M2020-12-31: $4.07M2021-12-31: $2.61M2022-12-31: $3.98M2023-12-31: $1.89M2024-12-31: $465.7K2025-12-31: $1.25M$1.25M
2009-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$1.25M+168.5%2026-03-30, From 2025-01-01
2024-12-31$465.7K-75.4%2026-03-30, From 2024-01-01
2023-12-31$1.89M-52.4%2025-03-28, From 2023-01-01
2022-12-31$3.98M+52.4%2024-04-01, From 2022-01-01
2021-12-31$2.61M-35.9%2023-03-29, From 2021-01-01
2020-12-31$4.07M+192.7%2022-03-30, From 2020-01-01
2019-12-31$1.39M-31.5%2021-03-30, From 2019-01-01
2018-12-31$2.03M-88.6%2020-03-27, From 2018-01-01
2017-12-31$17.76M+395.2%2019-03-22, From 2017-01-01
2016-12-31$3.59M+31.9%2018-03-29, From 2016-01-01
2015-12-31$2.72M+77.1%2017-03-30, From 2015-01-01
2014-12-31$1.54M+156.9%2016-03-25, From 2014-01-01
2013-12-31$597.7K+117.0%2016-03-25, From 2013-01-01
2012-12-31$275.4K+13.0%2015-03-26, From 2012-01-01
2011-12-31$243.7K+109.1%2014-03-26, From 2011-01-01
2010-12-31$116.5K-74.6%2013-03-28, From 2010-01-01
2009-12-31$459.5Kn/a2012-03-27, From 2009-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Immucell Corp (ICCC)2025-12-31$1.25M+168.5%
Alpha Teknova, Inc. (TKNO)2025-12-31$1.15M+2.0%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$1.13M-80.5%
Aspira Women's Health Inc. (AWHL)2025-12-31$16.0K-56.8%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$3.19M+517.2%
Volitionrx Ltd (VNRX)2025-12-31$89.6K-67.7%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$2.71M+41.4%
Neogen Corp (NEOG)2026-05-31$51.30M-51.0%
QuidelOrtho Corp (QDEL)2025-12-28$188.20M-3.5%

Compare ICCC, TKNO, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗